ArticleNPJ precision oncology2025
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.
Marcelo Sobral-Leite et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it